4.75
price down icon2.66%   -0.13
pre-market  Pre-mercato:  4.77   0.02   +0.42%
loading

Cara Therapeutics Inc Borsa (CARA) Ultime notizie

pulisher
Jan 09, 2025

Cara Therapeutics Shares Surge 20% After 1-for-20 Reverse Stock Split – Market - HPBL

Jan 09, 2025
pulisher
Jan 08, 2025

Cara Therapeutics (NASDAQ:CARA) Coverage Initiated at StockNews.com - Defense World

Jan 08, 2025
pulisher
Jan 07, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders - The Malaysian Reserve

Jan 07, 2025
pulisher
Jan 06, 2025

CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc.CARA - Business Wire

Jan 06, 2025
pulisher
Jan 02, 2025

Cara Therapeutics Files Certificate of Amendment for Reverse Stock Split and Shares Reduction - Defense World

Jan 02, 2025
pulisher
Jan 01, 2025

Cara Therapeutics, Inc. Announces Appointment of Joseph Stauffer as Chief Medical Officer - Marketscreener.com

Jan 01, 2025
pulisher
Jan 01, 2025

Cara Therapeutics, Inc. Announces Outcome from Dose- Finding Part A of the KIND 1 Study Evaluating Oral Difelikefalin for Mod Moderate-To-Severe Pruritus in Patients with Atopic Dermatitis - Marketscreener.com

Jan 01, 2025
pulisher
Jan 01, 2025

Cara Therapeutics discontinues neurological condition study as drug fails - Marketscreener.com

Jan 01, 2025
pulisher
Jan 01, 2025

Cara: Q2 Earnings Snapshot - Marketscreener.com

Jan 01, 2025
pulisher
Dec 31, 2024

Cara Therapeutics stock hits 52-week high at $4.26 By Investing.com - Investing.com Nigeria

Dec 31, 2024
pulisher
Dec 31, 2024

Cara shares jump 32% following reverse stock split - MSN

Dec 31, 2024
pulisher
Dec 31, 2024

Cara Therapeutics Shares Rise 20% Following Reverse Stock Split - MarketWatch

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market news: Coeptis Therapeutics Holdings declined by 96.03% whereas Baird Medical Investment Holdings +496.89% during mid day trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market today: Coeptis Therapeutics Holdings plunged by 95.98% whereas Baird Medical Investment Holdings gained over 201.90% in early trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Cara Therapeutics stock hits 52-week high at $4.26 - Investing.com India

Dec 31, 2024
pulisher
Dec 30, 2024

Cara Therapeutics announces effective date for 1-for-12 reverse stock split - Hartford Business Journal

Dec 30, 2024
pulisher
Dec 30, 2024

Cara Therapeutics, Inc. (NASDAQ:CARA) Given Average Rating of “Hold” by Brokerages - Defense World

Dec 30, 2024
pulisher
Dec 28, 2024

Cara Therapeutics announces 1-for-12 reverse stock split to regain Nasdaq compliance - MSN

Dec 28, 2024
pulisher
Dec 27, 2024

Cara Therapeutics to Implement 1-for-12 Reverse Stock Split - Marketscreener.com

Dec 27, 2024
pulisher
Dec 27, 2024

Cara Therapeutics enacts reverse stock split - Investing.com

Dec 27, 2024
pulisher
Dec 27, 2024

Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split - The Manila Times

Dec 27, 2024
pulisher
Dec 27, 2024

Cara Therapeutics (CARA) Announces 1-for-12 Reverse Stock Split to Maintain Nasdaq Listing - StockTitan

Dec 27, 2024
pulisher
Dec 25, 2024

Cara Therapeutics, Inc. (NASDAQ:CARA) Shares Bought by Fmr LLC - Defense World

Dec 25, 2024
pulisher
Dec 23, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders - The Eastern Progress Online

Dec 23, 2024
pulisher
Dec 23, 2024

StockNews.com Initiates Coverage on Cara Therapeutics (NASDAQ:CARA) - Defense World

Dec 23, 2024
pulisher
Dec 20, 2024

Cara Therapeutics Enters Agreement to Merge with Tvardi Therapeutics - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ARCH on Behalf of Shareholders - GlobeNewswire

Dec 19, 2024
pulisher
Dec 19, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders - The Malaysian Reserve

Dec 19, 2024
pulisher
Dec 18, 2024

Cara in all-stock merger deal with Tvardi - MSN

Dec 18, 2024
pulisher
Dec 18, 2024

Tvardi Therapeutics to go public in reverse merger with Connecticut company - The Business Journals

Dec 18, 2024
pulisher
Dec 18, 2024

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cara Therapeutics, Inc.CARA - The Eastern Progress Online

Dec 18, 2024
pulisher
Dec 18, 2024

Cara Therapeutics accepts buyout from Houston's Tvardi Therapeutics, ending 20-year run in Connecticut - New Canaan Advertiser

Dec 18, 2024
pulisher
Dec 18, 2024

Stamford’s Cara Therapeutics to merge with Houston biopharma firm - Hartford Business Journal

Dec 18, 2024
pulisher
Dec 18, 2024

CARA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cara Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Dec 18, 2024
pulisher
Dec 18, 2024

Cara Therapeutics and Tvardi Therapeutics To Merge - citybiz

Dec 18, 2024
pulisher
Dec 18, 2024

Cara stock in focus after Tvardi merger deal (CARA:NASDAQ) - Seeking Alpha

Dec 18, 2024
pulisher
Dec 18, 2024

Shareholder Alert: Ademi LLP Investigates Whether Cara Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - The Bakersfield Californian

Dec 18, 2024
pulisher
Dec 18, 2024

Cara Therapeutics to merge with Tvardi Therapeutics - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Cara Therapeutics Subsidiary to Merge with Tvardi Therapeutics in All-Stock Deal - MarketWatch

Dec 18, 2024
pulisher
Dec 18, 2024

Cara Therapeutics stock hits 52-week low at $0.24 amid market challenges By Investing.com - Investing.com South Africa

Dec 18, 2024
pulisher
Dec 18, 2024

BNP Paribas Financial Markets Has $179,000 Stock Holdings in Cara Therapeutics, Inc. (NASDAQ:CARA) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Cara Therapeutics stock hits 52-week low at $0.24 amid market challenges - Investing.com

Dec 17, 2024
pulisher
Dec 15, 2024

Cara Therapeutics (NASDAQ:CARA) Now Covered by Analysts at StockNews.com - Defense World

Dec 15, 2024
pulisher
Dec 05, 2024

Cara Therapeutics, Inc. (NASDAQ:CARA) Given Average Recommendation of “Hold” by Analysts - Defense World

Dec 05, 2024
$73.13
price down icon 0.08%
$22.19
price up icon 0.05%
$366.61
price up icon 1.18%
$43.17
price down icon 9.17%
biotechnology ONC
$177.88
price up icon 1.59%
$122.15
price down icon 3.73%
Capitalizzazione:     |  Volume (24 ore):